by clicking the arrows at the side of the page, or by using the toolbar.
by clicking anywhere on the page.
by dragging the page around when zoomed in.
by clicking anywhere on the page when zoomed in.
web sites or send emails by clicking on hyperlinks.
Email this page to a friend
Search this issue
Index - jump to page or section
Archive - view past issues
Australian Journal of Pharmacy : February 2005
Asthma? What asthma? Don't let asthma hold you back PBS Restricted Benefit: Patients who previously had frequent episodes of asthma while receiving treatment with oral corticosteroids or optimal doses of inhaled corticosteroids and who have been stabilised on concomitant inhaled salmeterol xinafoate and fluticasone propionate. † PLEASE NOTE CHANGE(S) TO PRODUCT INFORMATION Indications: Regular treatment of asthma where the use of a combination product is appropriate. This may include: patients on effective maintenance doses of long-acting ß2-agonists and inhaled corticosteroids, patients who are symptomatic on current inhaled corticosteroid therapy. Precautions: Short-acting ß2-agonists must be used for acute attacks, abrupt withdrawal, TB, transfer from systemic steroids, thyrotoxicosis, pregnancy, impaired adrenal function, unmasking of underlying eosinophilic conditions, unstable/deteriorating asthma, beta-blockers. Ritonavir (a highly potent cytochrome P450 3A4 inhibitor) can increase fluticasone propionate plasma concentrations, resulting in markedly reduced serum cortisol levels.† Adverse Events: arthralgia, tremor, tachycardia, palpitations, cardiac arrhythmias, headache, muscle cramps, oral candidiasis, hoarseness, paradoxical bronchospasm, hypersensitivity reactions† Dosage: Seretide must be used regularly for optimum benefit, even when asymptomatic. Overdosage: Potential risk of adrenal crisis in children† Contraindications: hypersensitivity. . . Metered dose inhaler: Adults, children >12 years: 2 inhalations BD (Seretide MDI 50/25 or Seretide MDI 125/25 or Seretide MDI 250/25); children = 4 years: 2 inhalations BD (Seretide MDI 50/25). Accuhaler: Adults, children >12 years: 1 inhalation BD (Seretide 100/50 Accuhaler or Seretide 250/50 Accuhaler or Seretide 500/50 Accuhaler); children = 4 years: 1 inhalation BD (Seretide 100/50 Accuhaler). PBS Price: Seretide MDI 50/25 $45.90 Seretide MDI 125/25 $59.32 Seretide MDI 250/25 $79.46 Seretide Accuhaler 100/50 $45.90 Seretide Accuhaler 250/50 $59.32 Seretide Accuhaler 500/50 $79.46. PLEASE REVIEW PRODUCT INFORMATION BEFORE PRESCRIBING. For full Product Information contact GlaxoSmithKline Australia Pty Ltd. 1061 Mountain Hwy, Boronia, Vic, 3155. ABN 47 100 162 481. ®Seretide and Accuhaler are registered trade marks of the GlaxoSmithKline Group of Companies. GLA1050 PC040418.